Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.170 | 2.380 | 0.210 |
Shares | 97.830 | 97.830 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.190 | 18.854 |
Price to Book | 3.501 | 4.052 |
Price to Sales | 2.080 | 4.748 |
Price to Cash Flow | 12.253 | 15.436 |
Dividend Yield | 0.765 | 0.482 |
5 Years Earnings Growth | 9.846 | 10.530 |
Number of long holdings: 101
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 7.96 | 450.80 | +0.73% | |
Gilead | US3755581036 | 6.79 | 66.17 | -2.40% | |
AstraZeneca ADR | US0463531089 | 6.33 | 78.18 | -0.79% | |
Regeneron Pharma | US75886F1075 | 5.80 | 980.57 | -0.33% | |
Amgen | US0311621009 | 5.78 | 306.50 | -0.94% | |
Moderna | US60770K1079 | 5.66 | 164.01 | +0.42% | |
Seagen Inc Ordinary Shares | US81181C1045 | 3.02 | - | - | |
Biogen | US09062X1037 | 2.89 | 218.06 | -3.17% | |
Alnylam | US02043Q1076 | 2.40 | 149.38 | -1.01% | |
Horizon Therapeutics PLC | IE00BQPVQZ61 | 2.30 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Kapital Plus P EUR | 10.38M | -4.78 | 6.19 | 5.64 | ||
Kapital Plus P2 EUR | 5.53M | 4.66 | 2.63 | 3.53 | ||
Kapital Plus I EUR | 90.65M | 4.63 | 2.48 | 3.38 | ||
DE000A2DU1Y2 | 22.37M | - | - | - | ||
Kapital Plus A EUR | 3.16B | 0.40 | -0.25 | 2.90 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review